Sanelfin AI Stocks - 2024: Returns for Moderna Inc (MRNA)
MRNA has no dividends.
Table and Chart of MRNA Performance
See what a $1,000 investment in MRNA is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| MRNA Returns | |
|---|---|
| Start Date | Jan-31-2019 |
| Start Price | $16.60 |
| End Date | Jan-17-2025 |
| End Price | $34.06 |
| # Prices | 73 |
| Min Date | Jul-31-2019 |
| Min Price | $13.10 |
| Max Date | Sep-30-2021 |
| Max Price | $384.86 |
| Total Return | 105.18% |
| Annualized Return | 12.54% |
| Current Value of $1,000 Purchase | $2,052 |
| Number Returns | 2,628 |
| Average Return | 222.11% |
| Number Profitable Returns | 1,534 |
| Percent Profitable Returns | 58.37% |
| Number Unprofitable Returns | 1,094 |
| Percent Unprofitable Returns | 41.63% |
| Profitable to Unprofitable Returns Ratio | 1.40 |
| MRNA Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $12,991,454,000 |
| Beta | 1.690 | Price to Sales | 2.56 |
| Earnings per Share | $-5.8100 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 1.122 |
| PRICE DATA | |
| 52 Week High | $170.47 |
| 52 Week Low | $31.94 |
| Analyst Target Price | $68.01 |
| 50-Day Moving Average | $42.33 |
| 200-Day Moving Average | $86.36 |
| FINANCIAL DATA | |
| Revenue per Share | $13.28 |
| Revenue | $5,081,000,000 |
| Profit Margin | -43.8% |
| Return on Equity | -17.5% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
MRNA Compare Returns with S&P 500
MRNA Trendline Chart
MRNA Moving Average Chart
MRNA Stock Return Map - See Patterns of Gains and Losses
MRNA Stock Returns/Purchase Dates